Abstract: The present invention relates to the pharmaceutical formulations comprising imatinib in solid dosage form reconstituted with a diluent just before use; preparation processes and use thereof.
Type:
Application
Filed:
November 30, 2011
Publication date:
May 7, 2015
Applicant:
Imuneks Farma Ilac Sanayi Ve Ticaret A.S.